Cite
HARVARD Citation
Gravel, S. et al. (2019). Use of 4β‐Hydroxycholesterol Plasma Concentrations as an Endogenous Biomarker of CYP3A Activity: Clinical Validation in Individuals With Type 2 Diabetes. Clinical pharmacology & therapeutics. 106 (4), pp. 831-840. [Online].